1 Min Read
Jan 22 (Reuters) - Sanofi Chief financial officer Jerome Contamine says :
* sees commercial, cost and tax synergies related to the acquisition of U.S firm Bioverativ by France’s Sanofi Further company coverage: (Paris Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.